Credits: Canva
Texas sues tylenol: Texas Attorney General Ken Paxton announced on October 28 that he has filed a lawsuit against the makers of Tylenol, accusing them of failing to warn consumers about possible risks of using the drug during pregnancy. According to USA Today, the lawsuit targets Johnson & Johnson and its spin-off company Kenvue, alleging they concealed information about Tylenol’s potential links to autism and attention deficit hyperactivity disorder (ADHD), violating state consumer protection laws.
“These corporations lied for decades, knowingly endangering millions to fill their own pockets,” Paxton said in a statement. “When they saw accountability coming, Johnson & Johnson tried to dodge responsibility by offloading their liability to another company. By holding Big Pharma accountable for poisoning our people, we will help Make America Healthy Again.”
Also Read: The 'BEFAST' Trick Could Help You Detect Your Stroke Before It Happens, According To Doctor
This marks the first lawsuit by a state government since President Donald Trump recently claimed that using Tylenol during pregnancy may raise the risk of autism — a claim that has limited scientific support.
Texas’s lawsuit, the first of its kind from any state, follows remarks made last month by President Trump and Health and Human Services Secretary Robert F. Kennedy Jr., who jointly issued new guidance discouraging pregnant women from using acetaminophen, the active ingredient in Tylenol. They cited it as a possible factor behind autism, sparking widespread concern and confusion among expecting mothers and healthcare experts alike.
The research surrounding Tylenol’s use in pregnancy remains unsettled. While a few studies have suggested a possible link between prenatal exposure and autism, many others have found no such connection. Major medical organizations have since pushed back against Trump and Kennedy’s statements, warning that the claims could spread unnecessary fear and misinformation.
This lawsuit is the first to formally adopt Trump’s theory that acetaminophen use in pregnancy might cause developmental disorders in children. The issue has long circulated among Kennedy’s followers, but Trump’s public comments brought it into mainstream discussion.
Kenvue has strongly defended Tylenol’s safety and dismissed Trump’s allegations, calling them misleading. Johnson & Johnson has also maintained that it has always acted responsibly in its product labeling, warning users only about the proven risk of liver damage from overuse.
Also Read: What's New In Trump's Health? A Recent 'Perfect' MRI Scan And The Will To Serve A 'Third Term'
In an official response, Kenvue stated that it was “deeply concerned by the spread of misinformation about the safety of acetaminophen and how it may affect women and children.” The company emphasized that acetaminophen remains “the safest pain relief option for pregnant women when needed throughout pregnancy.” Without it, they argued, women could face dangerous choices, either enduring untreated pain and fever, which may harm both mother and baby, or turning to more hazardous alternatives.
Over the past few years, hundreds of lawsuits have been filed nationwide by parents who believe their children developed autism or ADHD after prenatal Tylenol exposure. The largest group of such cases, consolidated in federal court in New York, was dismissed earlier this year due to insufficient scientific evidence. Plaintiffs have appealed the ruling, with an appellate hearing scheduled for November 17.
According to The New York Times, scientists have explored possible links between acetaminophen use during pregnancy and developmental disorders for years, but the research remains inconclusive.
Medical associations have rejected the Trump administration’s recent warning, reiterating that Tylenol is still considered the safest pain reliever for pregnant women. They warn that avoiding it altogether could be dangerous, as untreated high fevers and severe pain can pose serious health risks to both the mother and the unborn child.
Credits: Canva
Wet Wipes Waring: 59 people have fallen ill, with one dead, after using non-alcoholic, non-sterile, infected wet wipes in UK. The UK Health Security Agency (UKHSA) and Medicines and Healthcare products Regulatory Agency (MHRA) issued a warning, and said that there is still "an ongoing risk of infection associated with their use". The bacteria that is causing this infection is burkholderia stabilis or B. stabilis.

The UKHSA also in its warning included names of four different wet wipes and asked people to avoid using them.
The Pharmaceutical Journal noted that the UKHSA and MHRA published a joint statement that warned people that they should not use non-sterile, non-alcoholic wipes in their homes and first-aid kits.
After an outbreak investigation conducted by MHRA in 2025, four products were identified to be contaminated with Burkholderia stabilis. “There have been 59 confirmed cases of Burkholderia stabilis associated with some non-sterile alcohol-free wipe products — identified in an outbreak in the United Kingdom from January 2018 to 3 February 2026,” the statement said.
“A small number of cases continue to be detected. These have included some serious infections which have required hospital treatment and one death has been attributed to Burkholderia stabilis infection.”
UKHSA and MHRA is telling people to look out for wipes marked 'sterile' to be used on wounds or broken skin.
UKHSA on its official website notes: 'Burkholderia are a type of bacteria found naturally in the environment, including in soil and water. Burkholderia stabilis is one species within this group. While many people never encounter problems with this type of bacteria, it can cause serious infections in certain circumstances, particularly among vulnerable individuals.'
Read: Does Bigger Penis Help You Ski Better? Why Olympians Are Injecting Hyaluronic Acid - Explained
The UKHSA notes: "The risk of acquiring infection is generally very low. Infections can occur through contact with contaminated products on broken or damaged skin, or through introduction of bacteria through medical devices such as intravenous lines."
Days after it emerged that over 800 people had gone missing in Delhi during the first 27 days of 2026 and officials requested people to remain calm, Delhi Police has revealed this is false and such claims are being "pushed through paid promotion".
In a statement released on X today morning: "After following a few leads, we discovered that the hype around the surge in missing girls in Delhi is being pushed through paid promotion. Creating panic for monetary gains won't be tolerated, and we'll take strict action against such individuals."
Authorities across the capital claim that dispensing false information about life-altering information such as kidnappings and death through paid promotion can cause as well as amplify fear among the general public, which can massively ruin mental health and cause long-term damage to overall wellbeing.
Dr Kunal Bahrani, Chairman and Group Director, Neurology at Yatharth Hospitals, explained to Healthandme: "Incidents like this highlight how quickly fear can spread in today’s hyperconnected world and how deeply false news can impact mental wellbeing. When people are exposed to alarming information, especially involving safety and crime, the brain’s threat system switches on almost instantly. Stress hormones such as cortisol surge, increasing anxiety, restlessness, sleep disturbances and even physical symptoms like headaches or heart palpitations.
"Repeated exposure to frightening but unverified news can also condition the brain to remain in a constant state of alert, making individuals more irritable, emotionally overwhelmed and prone to panic. For children, elderly people and those already struggling with anxiety or depression, the psychological impact can be far more intense and long-lasting."
However, while many wonder how this form of promotion came into being, Reddit users are already pointing towards Rani Mukerji's Mardaani-3, a movie based on the kidnapping of minor girls as the source for this chaos.
Fear-mongering severely impacts mental health by triggering chronic stress, anxiety, and depression, often overloading the brain’s threat response system (amygdala) and leading to long-term damage.
Over time, constant exposure to exaggerated, alarming narratives fuels irrational fears and cognitive distortions such as catastrophizing. This constant state of fear can also lead to avoidance behaviors, hopelessness, and physical symptoms like headaches, poor sleep and a weakened immune system.
Dr Neetu Tiwari, MD Psychiatry Senior Resident, NIIMS Medical College & Hospital also told Healthandme: "When things like this happen around us, it creates a sense of panic and fear amongst parents and children. Our brain usually reacts as if the danger is real. The body then becomes alert, our heart beats faster than it should, and our mind stays at tense. Even if the news is proven to be false, this fear that has set in often takes time to settle down.
"Now this in turn causes a lot of trouble. It makes people feel unsafe, so people avoid going out, they worry more about loved ones, or may also keep checking their phones repeatedly for updates. This behavior can lead to anxiety, panic, disturbed sleep, and constant overthinking. Even when the news is fake, fear travels very quickly. And once fear enters our mind, calming down takes time.
"This is why sharing unverified information can unknowingly harm others especially children as it can lead them in feeling scared even to go to school, or sleep alone, or even step outside. In fact in some children this may even cause nightmares or these children become unusually clingy to parents or guardians which further leads to problem in social development and confidence.
Dr. Rajiv Mehta, senior consultant psychologist, Sir Gangaram Hospital added: "The society at large is very gullible and anxiety prone, as we have seen the rise in mental illnesses. The people who are already anxious will get more anxious, the people who are not anxious will get anxious and that will increase the mental instability in the persons.
"And what they and parents are going to do is take a lot of precautions towards their young kids by not allowing them to go outside, to play with the children and go out of society buildings. They will be very fearful and when children will be home bound, then they will spend more time on screens or will have altercations with their parents.
"People should not resort to such kind of things only for the sake of their own materialistic monetary benefit. That is highly condemnable if it has occurred because of these kind of reasons that movie is going to release and they are sensationalizing these things."
Data obtained from Press Trust of India suggests that a total of 807 people went missing between January 1 and 15, with an average of 54 people going missing every day. Of these, 509 were women and girls, and 298 were men. Among the total reported missing, 191 were minors and 616 were adults.
In an official statement, the police said that, while the data was recorded, January 2026 saw a "decline in the number of missing persons reports when compared with the corresponding period of previous years."
Officials had previously further clarified that no organized gang or criminal network has been found involved in cases of missing or abducted children in Delhi so far.
"Recent public discourse has raised concerns about the welfare of children in Delhi. We appeal to the citizens not to fall prey to the rumours about the spurt in the cases of missing children.
While denying such claims, we also warn rumour mongers of strict legal action for creating unnecessary panic and fear by misrepresenting data.
The safety of every child is of paramount importance to Delhi Police.
"Delhi Police is committed to serve 24x7 and making all out efforts to trace all missing persons and reunite them with distraught family members, at the earliest," they said in a statement released yesterday.
Credits: iStock
Cheaper copy of Wegovy by Hims & Hers for $49 has drawn tensions, with Novo Nordisk now approaching to take legal actions. The pill by Novo Nordisk is sold for $149. In a statement, Novo said, "The action by Hims & Hers is illegal mass compounding that poses a significant risk to patient safety. Novo Nordisk confirmed that the company will take legal and regulatory actions to protect patients.
“Novo Nordisk will take legal and regulatory action to protect patients, our intellectual property and the integrity of the US gold-standard drug approval framework. This is another example of Hims & Hers’ historic behaviour of duping the American public with knock-off GLP-1 products, and the FDA has previously warned them about their deceptive advertising of GLP-1 knock-offs,” the statement said.
Read: Wegovy Pills Now Available At Your Pharmacies, Here's What To Know About Its Usage
After the cheaper copy of the pill was launched by Hims & Hers, shares of Novo Nordisk and rival Eli Lilly fell by 7%. Whereas, stock for Hims & Hers initially spiked after the announcement, but pared gains after Novo said that it would fight the rollout.
Hims & Hers was previously offering compounded semaglutide, the active ingredient in Novo Nordisk's popular weight loss drug Ozempic and Wegovy, in injectable format. The company has now extended to offer the oral version.
Hims & Hers said that the Wegovy copy pill cost $49 for the first month and $99 with a 5-month plan. While semaglutide's patent is protected in the US until 2032, however, Hims & Hers claim that the copies are 'personalized' and therefore legal.
“This compounded product uses a different formulation and delivery system than FDA-approved oral semaglutide,” Hims & Hers said. “This once-a-day pill has the same active ingredient as Wegovy and empowers providers to tailor treatment plans specifically for those who prefer to avoid needles or need smaller doses to help to balance side-effects,” it said.
Novo Nordisk however, highlighted that it manufactures Wegovy pill by using SNAC technology. This technology helps in absorption when administered orally. Therefore, it is not clear how Hims & Hers copy formula could match that level of absorption.
Last year, Novo Nordisk and Hims & Hers partnered to offer weight loss jabs at a discounted price to telehealth company's customer. However, Novo Nordisk ended the collaboration just two months later, stating that Hims & Hers used 'deceptive' marketing that put patient safety at risk
While rival Eli Lilly does not have the weight loss pill yet, it is expected to launch orforglipron in the first half of this year. The pill is currently pending Food and Drug Administration approval.
Read: Eli Lilly Sends Weight-Loss Pill For Approval: Is Oral GLP-1 As Effective As The Injections?
“With the ... current legal backdrop, there is no reason why HIMS shouldn’t evaluate these launches for every subsequent weight loss product as the market continues to evolve,” Leerink analyst Michael Cherny said in a note to clients.
© 2024 Bennett, Coleman & Company Limited